Journal of Leukemia
Open Access

Inhibitors of B-Cell Receptor Signaling for the Treatment of Chronic Lymphocytic Leukemia

Tadeusz Robak

DOI: 10.4172/2329-6917.1000e101

Detection of BRAF V600E Mutation in Langerhans Cell Histiocytosis Using High-resolution Melting Analysis in Decalcified, Paraffin-embedded Tissue

Bin Fu, Zhongqing Wang, Xiaolin Li, Sa A Wang and Zhuang Zuo

DOI: 10.4172/2329-6917.1000101

Secondary Acute Myeloid Leukemia (sAML) Immediately after Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)

Sebastian Grosicki, Agnieszka Barchnicka, Ewa Bodzenta, Olga Haus and Anna Jaśkowiec

DOI: 10.4172/2329-6917.1000102

High-dose Glucocorticoid for the Treatment of Myeloid Sarcoma

Gonul Hicsonmez

DOI: 10.4172/2329-6917.1000103

Lenalidomide Therapy of Myelodysplastic Syndromes

Ota Fuchs, Anna Jonasova and Radana Neuwirtova

DOI: 10.4172/2329-6917.1000104

Dysregulation of the antigen-induced NF-κB signaling pathway in the development of human B-cells lymphomas

Nassima Messali, Pierre Genin and Robert Weil

DOI: 10.4172/2329-6917.1000105

Abl Kinase Domain Mutations in Imatinib-treated Egyptian Patients with Chronic Myeloid Leukemia

Yasser H Elnahass, Hossam K Mahmoud, Fahmy T Ali, Mohamed R Mohamed, Mahmoud M Said, Mohamad Abdel Moaty Samra,Mohamed AM Ali, Amir Salem and Wafaa H ElMetnawy

DOI: 10.4172/2329-6917.1000106

Expression and Function of the Eph Receptor Family in Leukemia and Hematopoietic Malignancies: Prospects for Targeted Therapies

Sara Charmsaz and Andrew W Boyd

DOI: 10.4172/2329-6917.1000107

The Current Molecular Site of the Myeloproliferative Neoplasms - TET-á-tête with the Jackpot but no LNK so far to Resolve Complexity

Oliver Bock